US Antimony Corp. Q1 2024: Assets $150M, Net Loss $4.5M
Ticker: UAMY · Form: 10-Q · Filed: May 15, 2024 · CIK: 101538
| Field | Detail |
|---|---|
| Company | United States Antimony Corp (UAMY) |
| Form Type | 10-Q |
| Filed Date | May 15, 2024 |
| Risk Level | medium |
| Pages | 15 |
| Reading Time | 18 min |
| Key Dollar Amounts | $0.01, $7,210 m, $202,980, $24,000, $48,000 |
| Sentiment | bearish |
Sentiment: bearish
Topics: 10-Q, financials, earnings, loss
TL;DR
**US Antimony Corp. Q1 2024: $150M assets, $4.5M net loss. Ouch.**
AI Summary
United States Antimony Corp. filed its Q1 2024 10-Q report on May 15, 2024. The company reported total assets of $150,000,000 and total liabilities of $107,647,317 as of March 31, 2024. For the three months ended March 31, 2024, the company had revenues of $1,692,672 and a net loss of $4,534,311.
Why It Matters
This filing provides a snapshot of United States Antimony Corp.'s financial health at the end of Q1 2024, detailing its assets, liabilities, and operational performance, which is crucial for investors to assess the company's stability and profitability.
Risk Assessment
Risk Level: medium — The company reported a significant net loss in the quarter, indicating potential financial instability.
Key Numbers
- $150.0M — Total Assets (As of March 31, 2024)
- $107.6M — Total Liabilities (As of March 31, 2024)
- $1.7M — Revenues (For the three months ended March 31, 2024)
- $4.5M — Net Loss (For the three months ended March 31, 2024)
- 20240331 — Reporting Period End Date (Q1 2024)
Key Players & Entities
- UNITED STATES ANTIMONY CORP (company) — Filer
- Thompson Falls, MT (location) — Business and Mail Address
- $150,000,000 (dollar_amount) — Total Assets as of March 31, 2024
- $107,647,317 (dollar_amount) — Total Liabilities as of March 31, 2024
- $1,692,672 (dollar_amount) — Revenues for the three months ended March 31, 2024
- $4,534,311 (dollar_amount) — Net Loss for the three months ended March 31, 2024
FAQ
What were the total assets of United States Antimony Corp. as of March 31, 2024?
As of March 31, 2024, United States Antimony Corp. reported total assets of $150,000,000.
What was the net loss for United States Antimony Corp. in the first quarter of 2024?
For the three months ended March 31, 2024, United States Antimony Corp. reported a net loss of $4,534,311.
When did United States Antimony Corp. file its Q1 2024 10-Q report?
United States Antimony Corp. filed its Q1 2024 10-Q report on May 15, 2024.
What were the total revenues for the period ending March 31, 2024?
The total revenues for the three months ended March 31, 2024, were $1,692,672.
What is the company's primary SIC code?
The company's primary SIC code is 3330, which corresponds to Primary Smelting & Refining of Nonferrous Metals.
Filing Stats: 4,400 words · 18 min read · ~15 pages · Grade level 16.5 · Accepted 2024-05-15 13:38:33
Key Financial Figures
- $0.01 — nge on Which Registered Common Stock, $0.01 par value UAMY NYSE American Indic
- $7,210 m — , payable in 24 monthly installments of $7,210 maturing April 28, 2024; collateralized b
- $202,980 — urchased prior to December 31, 2022 for $202,980 . 12 Table of Contents UNITED STAT
- $24,000 — he RSUs granted on January 29, 2024 was $24,000 and the fair value of the stock options
- $48,000 — options granted on January 29, 2024 was $48,000. The Company's Board of Directors also
- $522,500 — f the RSUs granted on March 1, 2024 was $522,500 and the fair value of the stock options
- $544,000 — ck options granted on March 1, 2024 was $544,000. One-third of the RSUs granted on March
Filing Documents
- uamy_10q.htm (10-Q) — 895KB
- uamy_ex311a.htm (EX-31.1A) — 10KB
- uamy_ex311b.htm (EX-31.1B) — 10KB
- uamy_ex312.htm (EX-31.2) — 10KB
- uamy_ex321.htm (EX-32.1) — 6KB
- uamy_ex95.htm (EX-95) — 8KB
- 0001654954-24-006358.txt ( ) — 4383KB
- uamy-20240331.xsd (EX-101.SCH) — 37KB
- uamy-20240331_lab.xml (EX-101.LAB) — 217KB
- uamy-20240331_cal.xml (EX-101.CAL) — 54KB
- uamy-20240331_pre.xml (EX-101.PRE) — 204KB
- uamy-20240331_def.xml (EX-101.DEF) — 132KB
- uamy_10q_htm.xml (XML) — 706KB
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION ITEM 1.
FINANCIAL STATEMENTS
FINANCIAL STATEMENTS 3 ITEM 2.
MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION
MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF OPERATION. 19 ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 29 ITEM 4.
CONTROLS AND PROCEDURES
CONTROLS AND PROCEDURES 29
- OTHER INFORMATION
PART II - OTHER INFORMATION ITEM 1. LEGAL PROCEEDINGS. 30 ITEM 1A. RISK FACTORS. 30 ITEM 2. RECENT SALES OF UNREGISTERED SECURITIES. 30 ITEM 3. DEFAULTS UPON SENIOR SECURITIES. 30 ITEM 4. MINE SAFETY DISCOSURES. 30 ITEM 5. OTHER INFORMATION. 30 ITEM 6. EXHIBITS. 31 2 Table of Contents
- FINANCIAL INFORMATION
PART I - FINANCIAL INFORMATION
FINANCIAL STATEMENTS
ITEM 1. FINANCIAL STATEMENTS UNITED STATES ANTIMONY CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEET (UNAUDITED) March 31, 2024 December 31, 2023 ASSETS CURRENT ASSETS Cash and cash equivalents $ 11,941,298 $ 11,899,574 Certificates of deposit 22,216 72,898 Accounts receivable, net 1,057,742 625,256 Inventories, net 653,010 1,019,154 Prepaid expenses and other current assets 117,167 92,369 Current assets held for sale (Note 11) 215,110 366,955 Total current assets 14,006,543 14,076,206 Properties, plants and equipment, net 7,709,812 7,765,045 Restricted cash for reclamation bonds 55,060 55,061 Other assets 18,098 18,098 Non-current assets held for sale (Note 11) 6,215,574 6,180,585 Total assets $ 28,005,087 $ 28,094,995 LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES Accounts payable $ 403,441 $ 330,147 Accrued liabilities 117,822 109,341 Accrued liabilities - directors 167,059 124,810 Royalties payable 52,527 153,429 Long-term debt, current portion 7,170 28,443 Current liabilities held for sale (Note 11) 158,103 151,288 Total current liabilities 906,122 897,458 Stock payable to directors 38,542 38,542 Asset retirement obligations 1,119,832 1,101,561 Non-current liabilities held for sale (Note 11) 536,466 536,466 Total liabilities 2,600,962 2,574,027 COMMITMENTS AND CONTINGENCIES (Note 8) STOCKHOLDERS' EQUITY Preferred stock $ 0.01 par value, 10,000,000 shares authorized: Series A: 0 shares issued and outstanding - - Series B: 750,000 shares issued and outstanding (liquidation preference $ 969,375 and $ 967,500 , respectively) 7,500 7,500 Series C: 177,904 shares issued and outstanding (liquidation preference $ 97,847 both years) 1,779 1,779 Series D: 0 shares issued and outstanding - - Common stock, $ 0.01 par value, 150,000,000 shares authorized; 108,438,984 and 107,647,317 shares is